Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere Commences Public Offering

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere announced after the close of the market on Monday that it intends to offer 13.6 million shares of its common stock in a public offering.

The shares will be priced at $2.20 per share and Nanosphere expects proceeds from the offering to be about $27.9 million. If the underwriters exercise their over-allotment option in full, net proceeds will be about $32.1 million, it added.

Nanosphere said it intends to use net proceeds from the offering for general corporate purposes and working capital. It had previously raised $35.3 million in a public offering announced in October 2009.

Piper Jaffray is acting as the sole book-running agent manager on the current offering and Roth Capital Partners will act as co-manager.

The offering is expected to close on May 13 and is being made pursuant to a prospectus filed by the firm in September 2009.

In early morning trading on Tuesday on Nasdaq, shares of Nanosphere were down 26 percent to $2.16.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.